AWM Investment Company’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-48,957
Closed -$631K 126
2022
Q2
$631K Sell
48,957
-5,743
-10% -$73.7K 0.1% 108
2022
Q1
$853K Buy
54,700
+34,719
+174% +$586K 0.11% 101
2021
Q4
$426K Hold
19,981
0.04% 113
2021
Q3
$560K Hold
19,981
0.06% 115
2021
Q2
$590K Hold
19,981
0.06% 116
2021
Q1
$639K Hold
19,981
0.07% 104
2020
Q4
$718K Hold
19,981
0.09% 95
2020
Q3
$759K Hold
19,981
0.12% 82
2020
Q2
$699K Hold
19,981
0.12% 79
2020
Q1
$689K Hold
19,981
0.18% 67
2019
Q4
$663K Hold
19,981
0.13% 73
2019
Q3
$507K Hold
19,981
0.11% 77
2019
Q2
$431K Hold
19,981
0.08% 85
2019
Q1
$340K Hold
19,981
0.07% 80
2018
Q4
$232K Buy
+19,981
New +$262K 0.05% 81
2018
Q3
Sell
-328,478
Closed -$4.17M 93
2018
Q2
$4.17M Buy
328,478
+7,759
+2% +$118K 0.7% 49
2018
Q1
$4.82M Buy
320,719
+17,818
+6% +$277K 0.93% 38
2017
Q4
$4.12M Buy
302,901
+22,700
+8% +$357K 0.8% 40
2017
Q3
$5.38M Buy
+280,201
New +$5.28M 0.94% 31

Other funds holding ZEAL

AWM Investment Company's ZEAL Position: Q3 2022 in Review

AWM Investment Company sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 48,957 shares — an estimated $631K sold.

AWM Investment Company first reported a position in ZEAL in Q3 2017 and held it in 19 quarters. The position peaked at $5.38M in Q3 2017. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.

  • AWM Investment Company reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • AWM Investment Company sold 48,957 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $631K.
  • AWM Investment Company first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 19 quarters.
  • AWM Investment Company's Zealand Pharma A/S American Depositary Shares position peaked at $5.38M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.

Based on AWM Investment Company's 13F filing for Q3 2022, filed 14 Nov 2022.